Mass. health care leaders want RFK Jr. to expand telehealth
The big picture: The controversial Health and Human Services secretary is accepting input from hospitals and health care groups nationwide to cut red tape.
State of play: The Massachusetts Health & Hospital Association (MHA) sent its wish list last week, asking the Centers for Medicare & Medicaid Services (CMS) to standardize the process for obtaining prior authorization across health plans, reviving certain home health programs and expanding telehealth.
The MHA also asked the federal government to eliminate prior authorization requirements for Medicare Advantage patients who receive certain services after they're discharged from a hospital.
Zoom in: Telehealth has become increasingly common since the COVID-19 pandemic, but several barriers to access and coverage remain, health officials say.
The MHA's asks range from expanding coverage for audio-only telehealth to letting more practitioners perform telehealth visits and get paid (think occupational therapy, physical therapy or speech-language pathology appointments).
The MHA also asked the CMS to revive a pandemic-era program that lets patients do cardiac or pulmonary rehab from home, among other programs that have since lapsed.
The MHA did not respond to requests for an interview about its recommendations.
Zoom out: Kennedy has previously expressed support for telehealth, in part to increase health care access in rural communities.
He and other federal officials pledged last month to cut red tape that complicates the prior authorization process.
That pledge includes standardizing electronic prior authorization requests, reducing the number of medical services that require it and ensuring medical professionals review all clinical denials, NPR reported.
Yes, but: The focus of MHA's request for information (RFI) is to cut red tape and spending, which may not bode well for requests to revive old programs.
The executive order that sparked the RFI called for implementing the 10-to-1 rule, meaning that "for every new regulation introduced, at least 10 existing regulations must be eliminated."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
7 minutes ago
- Newsweek
Trump Brushes Off Major Success From First Term: 'Long Time Ago'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. President Donald Trump on Wednesday brushed off what is widely considered to be among the biggest uncontested successes of his first term while reacting to Health and Human Services Secretary Robert F. Kennedy Jr.'s move to pull $500 million in funding for next-generation mRNA-based vaccines to tackle viruses like Covid, H5N1 and the flu. "You were the driving force behind Operation Warp Speed, these mRNA vaccines that are the gold standard," a reporter asked Trump during a White House event on Wednesday. Operation Warp Speed was a 2020 public-private partnership, initiated by the first Trump administration, aimed at accelerating the development and distribution of a COVID-19 vaccine. At the time, it was almost universally accepted that an effective vaccine for the coronavirus was at least 18 months to two years away. Trump's operation did it in less than a year. "Now, your health secretary is pulling back all the funding for research, he's saying that the risks outweigh the benefits, which puts him at odds with the entire medical community, and with you," the reporter continued. "What's going on?" "Research on what?" Trump asked. "Into mRNA vaccines," she clarified. "Well, we're going to look at that," the president replied. "We're talking about it and they're doing a very good job, and you know, that is a pass." Trump went on to briefly acknowledge the success of Operation Warp Speed before dismissing it. "Operation Warp Speed was, whether you're a Republican or Democrat, considered one of the most incredible things ever done in this country," the president said. "The efficiency, the way it was done, the distribution, everything about it has been amazing." Then he added: "But, you know, that was now a long time ago. And we're onto other things, but we are speaking about it. We have meetings about it ... we're looking for other answers to other problems, to other sicknesses and diseases and I think we're doing really well." This is a breaking news story. Updates to follow.
37 minutes ago
RFK Jr. cancels at least $500M in mRNA vaccine funding. What are the implications?
The Department of Health and Human Services (HHS) announced this week it is beginning a "coordinated wind-down" of federally funded mRNA vaccine development. This includes terminating awards and contracts with pharmaceutical companies and universities and canceling 22 investment projects worth nearly $500 million. While some final-stage contracts will be allowed to be completed, no new mRNA-based projects will be initiated, the HHS said. "We reviewed the science, listened to the experts, and acted," Secretary Robert F. Kennedy Jr. said in a press release on Tuesday. "The data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate." Infectious disease experts told ABC News that mRNA technology has been very successful in preventing severe disease, hospitalization and deaths, especially during the COVID-19 pandemic, potentially affecting our preparedness for future pandemics. Ending mRNA vaccine development may also squash enthusiasm for technology that has been hailed as a potential promise for cancer and HIV vaccines. "It's an excellent technology. It saved millions of lives and did it in a remarkably safe manner," Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, told ABC News. "I think it's an unscientific move, a move that goes against existing science." Affecting future pandemic preparedness Last year, the federal government awarded Moderna $176 million to help expedite the development of an mRNA-based bird flu vaccine. Earlier this year, the vaccine manufacturer received an additional $590 million to speed up the development. However, in its press release, the HHS said it was cancelling the award, which has been issued by the Biomedical Advanced Research and Development Authority, to Moderna and the University of Texas Medical Branch. Dr. Peter Hotez, a professor of pediatrics and molecular virology at Baylor College of Medicine in Houston, told ABC News the wind-down is a blow to pandemic preparedness. During the COVID-19 pandemic, mRNA technology demonstrated its ability to scale up vaccine production quickly. "The message to the companies will clearly be that they can no longer rely on the U.S. government for supporting any mRNA vaccine work, which is unfortunate, or even tragic, because the mRNA platform is one of the few that we have for pandemic threats in terms of something that we can make a vaccine for very quickly," he said. "So what, what Mr. Kennedy's and HHS' actions are doing is weakening our pandemic preparedness and weakening our biosecurity." The HHS also said it was terminating contracts with Emory University and Tiba Biotech. Researchers had been working on using mRNA technology to develop a nasal influenza vaccine. Emory has also been working on a dry powder inhaled mRNA-based treatment for influenza and COVID with TFF Pharmaceuticals, funded by BARDA. It's unclear if this is one of the 22 contracts that have been canceled. Hotez said COVID-19 and influenza can have very severe consequences and that it's incorrect for Kennedy to mischaracterize them as harmless upper respiratory infections. "COVID and flu are not [only] upper respiratory infections," he said. "The reason we develop vaccines for COVID and flu is because they cause systemic illness and lower respiratory infections and cardiovascular illness. … This is part of the anti-vaccine playbook, to diminish the severity of the illness, and to say something like influenza or COVID is an upper respiratory infection, it's just very, very misleading." Cancer vaccines, HIV treatments mRNA technology has also been hailed as a potential vector for providing personalized cancer treatments and protection against HIV transmission. In February, a small preliminary study published in the journal Nature found a personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery. Additionally, a University of Florida study found an experimental mRNA vaccine paired with anticancer drugs boosted an anti-tumor response. Meanwhile, earlier this month, an early-stage clinical trial found two mRNA vaccine candidates triggered a strong immune response against HIV. Results from the trial showed that 80% of participants who received one of two vaccine candidates produced antibodies. Although antiretroviral therapy has been the standard treatment for HIV infection, and is effective in preventing transmission, it is hard to scale up worldwide due to its costs, making mRNA vaccines to be anti-HIV vaccine strategy, researchers from the U.S., Germany and Romania wrote in a commentary in June 2022. It's unclear if any of the BARDA contracts are specifically for cancer vaccines or HIV vaccine development, but Hotez said the real damage is denigrating mRNA technology. "What he's done is he's caused uncertainty among the American people about the safety and effectiveness of mRNA for any condition, including cancer," he said. "And in fact, mRNA technology is probably the most exciting technology we have now for cancer and also other non-communicable illnesses. … Even though he may not be canceling any cancer vaccine contracts through BARDA, it may have collateral deleterious in terms of squashing enthusiasm for the technology." Offit added that mRNA is not brand-new technology. mRNA was discovered independently by two teams in 1961, including French and American molecular biologists. Breakthroughs in developing mRNA vaccines began in the early 2000s, eventually leading to the development of COVID-19 vaccines in 2020. This makes the technology primed for being used in other avenues, such as cancer vaccines, Offit said. "We now know a lot about mRNA," he said. "We know a lot about its safety. We know a lot about its safety in young children, including babies. We know a lot about it regarding gene therapy. We know a lot about this safety in terms of pregnant people, where that's often not the case with new technology." Offit went on, "So you have this background of information that enables you to move forward in a number of areas, involving babies or involving pregnant women. But there was an attempt by this administration to squelch that, to sit on all that for no good reason other than a political reason."
Los Angeles Times
an hour ago
- Los Angeles Times
Deaths linked to Eaton and Palisades fires could top 400, new study suggests
By all accounts, the January firestorms that decimated thousands of homes and killed 31 people in Los Angeles County were the most devastating in the region's history. But new research argues that the Eaton and Palisades fires may have been far more deadly than what's reflected in coroner reports. A research letter published Wednesday in the Journal of the American Medical Association estimates the county experienced 440 more deaths than typically expected between Jan. 5 and Feb. 1 — a period that began just days before the fires exploded. This higher number of deaths, the study notes, likely reflect such health damaging influences as increased exposure to poor air quality, or delays and interruptions in health services caused by the fires. While the immediate effects of wildfire and other climate-driven disasters are starkly apparent in hard-hit communities, the lingering consequences can be challenging to quantify. Toxic smoke exposure and environmental damage stemming from wildfires can linger months, and even years, after the flames are extinguished. 'Attributing deaths properly to a wildfire is just almost an impossible task,' said Andrew Stokes, an associate professor at Boston University and a mortality demographer who co-authored the research letter. 'The research highlights the need for these types of modeling efforts to really get at the true burden of these disasters.' To generate their findings, study authors compared recorded deaths in Los Angeles County from Jan. 5 to Feb. 1 to those tallied during the same period in 2018, 2019 and 2024. (They excluded the years 2020 through 2023 when fatalities were significantly higher due to COVID.) According to their models, 6,371 deaths were recorded during the nearly month-long period during the fires compared to 5,931 deaths that were expected based on data from past years. Official death counts often rely on easily identifiable causes, including burns and smoke inhalation. But those numbers sometimes fail to capture the complete toll of a natural disaster. According to the county medical examiner, 19 people died in the Eaton fire and 12 people were killed in the Palisades fire. Many who perished were eventually found among the remnants of their destroyed properties. But the study argues that the actual deaths attributable to the fires were more than 14 times the official count. 'The differences are staggering,' Stokes said. Heat waves, hurricanes and other disasters have been the subject of similar research, but wildfires can be challenging to study when they erupt in rural, sparsely populated regions. Since the Palisades and Eaton fires occurred in 'one of the most densely populated areas of the nation, it was possible using national mortality statistics to establish a reliable baseline trend to estimate excess deaths,' Stokes said. 'What we've done here would be almost impossible to do for the Camp fire or other other wildfires that occurred in more rural parts of the state or country,' he said. Still, Stokes notes that the study isn't the full picture of the effects. Firefighters and other first responders — along with residents inside and outside the fire zones — could face future health issues stemming from exposure to smoke and ash. During the January blazes, fire-related hospital visits for smoke exposure jumped significantly across Los Angeles County, according to the Department of Public Health. But wildfire smoke can drift hundreds of miles and the specific number of deaths and hospitalizations tied to exposure are often not well-known until months and years after natural disasters. A study published last year by the UCLA Luskin Center for Innovation found an estimated 55,000 premature deaths in an 11-year span from inhaling fine particulate matter known as PM2.5, or soot, from wildfires. 'What we've done here is what we call a rapid assessment of the LA wildfire mortality,' Stokes said. 'And as such, we only focus on the acute period in which the wildfires were burning in Los Angeles. But we hope that there will be further research to evaluate the long tail of these wildfires.'
